Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Pharmaron Beijing Co., Ltd. (300759.SZ)

Compare
22.40
+0.34
+(1.54%)
At close: 3:04:58 PM GMT+8

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 3.46B
Earnings 371.55M

Q1'24

Q2'24

Q3'24

Q4'24

0
1B
2B
3B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

17.70 Low
29.39 Average
22.40 Current
38.00 High

Earnings Estimate

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2224
Avg. Estimate 0.170.230.961.1
Low Estimate 0.170.20.890.88
High Estimate 0.170.261.041.24
Year Ago EPS 0.10.160.630.96

Revenue Estimate

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 111212
Avg. Estimate 2.98B3.48B13.83B15.62B
Low Estimate 2.98B3.48B13.54B14.79B
High Estimate 2.98B3.48B14.08B16.33B
Year Ago Sales 2.67B2.93B12.28B13.79B
Sales Growth (year/est) 11.75%18.52%12.66%13.26%

Earnings History

Currency in CNY 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.190.210.260.25
EPS Actual 0.10.160.180.19
Difference -0.09-0.05-0.08-0.07
Surprise % -46.25%-24.96%-31.00%-25.49%

EPS Trend

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.170.230.961.1
7 Days Ago 0.220.281.011.13
30 Days Ago 0.220.281.011.13
60 Days Ago 0.280.371.071.22
90 Days Ago 0.280.371.061.22

EPS Revisions

Currency in CNY Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 111--
Up Last 30 Days 111--
Down Last 7 Days ------1
Down Last 30 Days ------1

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
300759.SZ 62.18%45.96%53.88%14.49%
S&P 500 6.92%5.09%8.78%14.15%

Related Tickers

6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
285.400
-1.25%
 
IKNA Ikena Oncology, Inc.
1.1100
0.00%
 
ZBIO Zenas BioPharma, Inc.
8.92
+7.08%
 
ENTA Enanta Pharmaceuticals, Inc.
5.10
+3.45%
 
PRAX Praxis Precision Medicines, Inc.
33.79
+13.29%
 
PYXS Pyxis Oncology, Inc.
0.9633
+3.15%
 
ALK-B.CO ALK-Abelló A/S
148.60
+1.36%
 
NMRA Neumora Therapeutics, Inc.
0.6468
+2.67%
 
XFOR X4 Pharmaceuticals, Inc.
0.1908
-2.30%
 
FTRE Fortrea Holdings Inc.
5.29
+5.38%